(Q36445532)

14 August 2017

1 reference

title

An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases (English)

1 reference

14 August 2017

4

1 reference

14 August 2017

David Diemert

3

0 references

Maria Elena Bottazzi

series ordinal

1

object named as

Maria Elena Bottazzi

1 reference

14 August 2017

Aaron P Miles

2

1 reference

14 August 2017

publication date

1 April 2006

1 reference

Expert Review of Vaccines

14 August 2017

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

189-198

1 reference

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Recent developments in tuberculosis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Vaccines as instruments of foreign policy. The new vaccines for tropical infectious diseases may have unanticipated uses beyond fighting diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Public-private partnership: from there to here

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Hookworm: "the great infection of mankind".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

Health Innovation Networks to Help Developing Countries Address Neglected Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.2.189

21 January 2018

Identifiers

DOI

10.1586/14760584.5.2.189

1 reference

14 August 2017

1 reference